Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study
The Journal of Clinical Endocrinology & Metabolism · 14.07.2023 · 108 (8) · 2065-2077
DOI: 10.1210/clinem/dgad030 ↗Kurz gefasst
Beobachtungsstudie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, online erschienen am 23.01.2023. Verfasst von Filippo Biscarini und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK. Hauptthemen laut MEDLINE: Graves Ophthalmopathy, Gastrointestinal Microbiome, Graves Disease, Hyperthyroidism. Die Arbeit wurde bisher 74-mal zitiert (Crossref) und nennt 63 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Marie-Sklodowska Curie Industry Industry-Academia Pathways and Partnerships.
Abstract (Originalsprache)
Context
Gut bacteria can influence host immune responses but little is known about their role in tolerance-loss mechanisms in Graves disease (GD; hyperthyroidism caused by autoantibodies, TRAb, to the thyrotropin receptor, TSHR) and its progression to Graves orbitopathy (GO).
Objective
This work aimed to compare the fecal microbiota in GD patients, with GO of varying severity, and healthy controls (HCs).
Methods
Patients were recruited from 4 European countries (105 GD patients, 41 HCs) for an observational study with cross-sectional and longitudinal components.
Results
At recruitment, when patients were hyperthyroid and TRAb positive, Actinobacteria were significantly increased and Bacteroidetes significantly decreased in GD/GO compared with HCs. The Firmicutes to Bacteroidetes (F:B) ratio was significantly higher in GD/GO than in HCs. Differential abundance of 15 genera was observed in patients, being most skewed in mild GO. Bacteroides displayed positive and negative correlations with TSH and free thyroxine, respectively, and was also significantly associated with smoking in GO; smoking is a risk factor for GO but not GD. Longitudinal analyses revealed that the presence of certain bacteria (Clostridiales) at diagnosis correlated with the persistence of TRAb more than 200 days after commencing antithyroid drug treatment.
Conclusion
The increased F:B ratio observed in GD/GO mirrors our finding in a murine model comparing TSHR-immunized with control mice. We defined a microbiome signature and identified changes associated with autoimmunity as distinct from those due to hyperthyroidism. Persistence of TRAb is predictive of relapse; identification of these patients at diagnosis, via their microbiome, could improve management with potential to eradicate Clostridiales.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Infection & Immunity, School of Medicine, Cardiff University, Cardiff, CF14 4XW, UK.
- Department of Bioinformatics, Parco Tecnologico Padano Srl (PTP), Lodi, 26900, Italy.
- Institute of Agricultural Biology and Biotechnology, Italian National Research Council (CNR), Milan, 20133, Italy.
- Department of Clinical Sciences and Community Health, University of Milan, Milan, 35-I-20122, Italy.
- Graves' Orbitopathy Center, Endocrinology, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan, Milan, 35-I-20122, Italy.
- Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, 45147, Germany.
ORCID-Profile: Pete Taylor, Anja Eckstein, Mario Salvi, Julian R Marchesi, Marian Ludgate
Förderung
- Marie-Sklodowska Curie Industry Industry-Academia Pathways and Partnerships
Zitieren
APA
Biscarini, F., Masetti, G., Muller, I., Verhasselt, H. L., Covelli, D., Colucci, G., Zhang, L., Draman, M. S., Okosieme, O., Taylor, P., Daumerie, C., Burlacu, M. C., Marinò, M., Ezra, D. G., Perros, P., Plummer, S., Eckstein, A., Salvi, M., Marchesi, J. R., & Ludgate, M. (2023). Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study. The Journal of Clinical Endocrinology & Metabolism, 108(8), 2065-2077. https://doi.org/10.1210/clinem/dgad030
Vancouver
Biscarini F, Masetti G, Muller I, Verhasselt HL, Covelli D, Colucci G, et al. Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study. The Journal of Clinical Endocrinology & Metabolism. 2023;108(8):2065-2077. doi:10.1210/clinem/dgad030
BibTeX
@article{Biscarini2023,
author = {Biscarini, Filippo and Masetti, Giulia and Muller, Ilaria and Verhasselt, Hedda Luise and Covelli, Danila and Colucci, Giuseppe and Zhang, Lei and Draman, Mohd Shazli and Okosieme, Onyebuchi and Taylor, Pete and Daumerie, Chantal and Burlacu, Maria-Cristina and Marinò, Michele and Ezra, Daniel George and Perros, Petros and Plummer, Sue and Eckstein, Anja and Salvi, Mario and Marchesi, Julian R and Ludgate, Marian},
title = {Gut Microbiome Associated With Graves Disease and Graves Orbitopathy: The INDIGO Multicenter European Study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
volume = {108},
number = {8},
pages = {2065--2077},
doi = {10.1210/clinem/dgad030}
}
EUVIMED